SCHEMBL18152810

SCHEMBL18152810

Cc1nc2c([N+](=O)[O-])c(Cc3ccc(F)cc3)c(Br)cc2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MDM2 Q00987 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ PTGS1 P23219 1/20 0.39
▸ PTGS2 P35354 1/20 0.39
▸ POLB P06746 3/20 0.37
▸ MAPT P10636 3/20 0.37
▸ SOS1 Q07889 1/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ ALKBH3 Q96Q83 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ GRIN2D O15399 1/20 0.36
▸ GRIN3B O60391 1/20 0.36
▸ GRIN1 Q05586 1/20 0.36
▸ GRIN2A Q12879 1/20 0.36
▸ GRIN2B Q13224 1/20 0.36
▸ GRIN2C Q14957 1/20 0.36
▸ GRIN3A Q8TCU5 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18152622 0.88 MGMT (0.39) POLBMAPTCYP1A2GRIN2DGRIN3B
SCHEMBL18152714 0.79 ALDH1A1 (0.40) SMN1; SMN2POLBMAPTCYP1A2CYP2C9
SCHEMBL28195339 0.77 SMN1; SMN2 (0.46) MDM2SMN1; SMN2PTGS1PTGS2POLB
SCHEMBL18152723 0.76 HTT (0.35) MDM2SMN1; SMN2PTGS1PTGS2MAPT
SCHEMBL18152712 0.75 GRIN2D (0.38) POLBMAPTGRIN2DGRIN3BGRIN1
SCHEMBL20309801 0.75 KCNH2 (0.51) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18152696 0.68 RIPK1 (0.37) SMN1; SMN2POLBMAPTCYP1A2CYP2C9
SCHEMBL2004140 0.68 GRIN2D (0.40) MDM2SMN1; SMN2GRIN2DGRIN3BGRIN1
SCHEMBL28195340 0.67 SMN1; SMN2 (0.45) MDM2SMN1; SMN2PTGS1PTGS2POLB
SCHEMBL28854614 0.65 MEN1 (0.39) MDM2SMN1; SMN2MAPTALDH1A1MGMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283077-A2 BROMODOMAIN INHIBITOR Celgene Quanticel Research, Inc. (US) 2018-02-21 — — EP disclosed
WO-2016168682-A2 BROMODOMAIN INHIBITOR CELGENE QUANTICEL RESEARCH, INC. (US) 2016-10-20 — — WO disclosed
Send feedback